Livers of dogs which were microfilaremic due to infection with Dirofilaria immitis were studied after the
administration of diethylcarbamazine. Most dogs had a severe shock-like clinical reaction. The main hepatic features were congestion and hemorrhage around the central vein and irregularly scattered foci of inflammation. The severity of the vascular reaction was associated with the number of microfilariae in the livers. Mast cells associated with the vascular reaction were not degranulated, suggesting that histamine-mediated anaphylaxis was not the cause of the reaction. The observations suggest that the mediator of the hepatic vascular reaction originates from the microfilariae and is influenced or activated by diethylcarbamazine.
Diethylcarbamazine is an effective drug in preventing Dirofiluria immitis infection in dogs.', l o However a shock-like reaction may occur when diethylcarbamazine is given to dogs with m i c r~f i l a r e m i a .~.~*~~, l 3 Characterized by vascular pooling in the visceral circulation and in particular the liver, this reaction has been postulated as being due to a systemic type I hypersensitivity (anaphylaxis)' mediated by vasoactive amines released from degranulating mast cells.6 However, this was not confirmed by later work which suggested that hypovolemic shock occurred in the diethylcarbamazine reaction due to constriction of the hepatic vein by substances liberated by mi~rofilanae.~
Materials and Methods
Twenty-six dogs of mixed breed and of both sexes, in good general health, but infected by D. immitis were obtained from a local pound. Their age was estimated from dentition and vaned from two to seven years. Following oral treatment with diethylcarbamazine (10 mg/kg bodyweight) the dogs were observed for clinical signs ofthe diethylcarbamazine reaction.2 This usually commenced within 90 minutes of dosing. One dog died during the clinical reaction and the remainder were then either killed by intravenous barbiturate injection at the peak of the reaction (30 to 60 minutes after commencement) (group I) or they were kept for further experimentation (group 11). The dogs in group I consisted of seven dogs which reacted to diethylcarbamazine and eight which had no clinically evident reaction. All dogs in group I1 reacted clinically to the initial treatment with diethylcarbamazine. Recovery from the clinical reaction took approximately six hours. Dogs in group I1 were subsequently vaccinated against distemper, hepatitis and parvo-virus, treated with anthelmintics, housed in an air-conditioned ward of the Queensland University Faculty of Veterinary Science Small Animal Hospital, and were fed a balanced commercial dry dog food. These dogs were submitted to weekly trials, varying from two to eight trials in total and involving the use of various drugs, in an attempt to block the clinical reaction following diethylcarbamazine dosage. On separate occasions prior to diethylcarbamazine administration, each dog was treated with up to two of the following drugs: dexamethasone, atropine sulphate, propanalol, aprotinin, phentolamine mesylate, lodoxamide ethyl, lodoxamide tromethamine, naloxone, methysergide and indomethacin. No residual side-effects to the use of these drugs were apparent clinically, and only in dogs given dexamethasone were the clinical signs of the diethylcarbamazine reaction blocked (Boreham and Atwell, unpublished observation). Dogs in group I1 were killed by intravenous barbiturate administration following observation of the clinical reaction to the final treatment with diethylcarbamazine; no other drug was used in conjunction with this final treatment. Microfilarial (D. immitis) status was assessed by presence only (group I) and by counts (group 11) based on the modified Knott's test procedure."
Following necropsy, lung, liver, kidney and intestinal tissues were fixed in neutral phosphate buffered formalin. Paraffin-embedded sections were prepared by conventional methods and stained with hematoxylin and eosin (HE), Giemsa, toluidine blue, azan, and Perk' Prussian blue.
The numbers of microfilariae observed in the liver sections were assessed on a negative to ++++ scale. Because of uneven distribution of the microfilariae within the sections, an average assessment over the complete tissue section at high power magnification (x400) was made. Approximately one micro-filaria per field was assessed as ++++, reducing proportionally to +, indicating one to two microfilariae per complete tissue section.
Results
The severity of both the clinical reaction to diethylcarbamazine administration as defined previously2 and the microscopic vascular changes in the liver of each dog is indicated in table I. The number of microfilanae within the liver are also indicated, using the graded scale. The data for group I1 relate to the final treatment with diethylcarbamazine. In general, the correlation between the severity of the clinical reaction and the vascular changes in liver was good. However, three dogs in group I1 (numbers 16, 17, 18) had moderate or severe liver reactions with no clinically apparent illness (table I).
At post-mortem examination, the most severe change was a dark swollen liver which oozed blood on sectioning. The occasional dog had small quantities (50 to 100 ml) of serosanguineous peritoneal fluid. Gall bladder edema and fibrin deposition on the surface of the liver and between the lobes was frequent. Other gross findings were referable to variable heartworm burdenssome dogs had patchy congestin of the lungs.'
The main microscopic features in the severely affected livers of both groups were extensive congestion, hemorrhage and occasional thrombus formation * See text for explanation.
All dogs in group I were assessed positive-not quantitated. Group I dogs had a single challenge only.
around the central vein. Hepatocytes surrounding the congested and hemorrhagic area were frequently swollen and had a foamy appearance ( fig. 1 ). Associated hepatic cell necrosis was infrequent. Macrophages that contained some bile pigment and variable quantities of hemosiderin were also present, particularly in dogs in group I1 which had been subjected to repeated challenges with diethylcarbamazine. In addition, early mild fibroplasia around the central veins was apparent in the livers of some dogs of group 11. These were the only microscopic features which differed between the livers of the dogs in each group. The portal areas were in general not affected, although there was occasional congestion of the veins in this area and dilation of the lymphatics. One prominent feature was the marked dilation of the lymphatics associated with the larger hepatic veins. These usually contained highly proteinaceous lymph, and the veins quite frequently were constricted ( fig. 2) . Perivascular edema and hemorrhage were also present ( fig. 3) . The distribution of the vascular lesions within the liver sections was variable, even in the most severely affected. Some central veins had no associated congestion or hemorrhage, and some of the larger hepatic veins and accompanying lymph vessels had no lesions.
All livers examined had irregularly scattered foci of inflammation (figs. 2, 3). These varied from extensive to small clusters of five to ten cells. Many inflammatory foci were associated with the vascular changes around the small central veins and the larger hepatic veins. These foci tended to be larger than the ones randomly scattered in the remaining tissue. In general, the eosinophil was the predominant inflammatory cell, but lymphocytes, neutrophils and mixed inflammatory cell infiltrates were frequent. Many of the foci were associated with microfilariae; in these cases eosinophils were prominent ( fig. 4) . Foci of different cellular composition were sometimes present within the same liver section. These foci were not present in the other tissues examined.
Most microfilariae were seen in larger vessels and sinusoids without evident host response ( fig. 5) . The number of microfilariae in the liver appeared to have no relationship to the blood microfilarial count at the time of diethylcarbamazine challenge, but had a distinct correlation with the severity of vascular change (table  I) . Mast cells with metachromatic cytoplasmic granules were present in small to moderate numbers, mainly associated with the larger vessels in both reactive and non-reactive livers (figs. 6, 7). The occasional mast cell was also present in the inflammatory foci.
Discussion
Some of the vascular changes in the livers of dogs included in this report are similar to those reported in diethylcarbamazine-challenged microfilaremic dogs5 These changes are consistent with shock due to circulatory f a i l~r e .~. '~ The causes of such shock include hemorrhage, acute fluid loss (e.g., severe diarrhea), sepsis including endotoxemia, neurogenic disorders and anaphylaxis. In some forms, particularly hemorrhagic shock, disseminated intravascular coagulation may be a complicating factor.I4 This latter condition has also been reported in clinical heartworm disease and may lead to circulatory collapse.'
The clinical signs and liver lesions reported in an earlier study5 were considered to be typical of a type I hypersensitivity reaction, i.e., anaphylactic shock. It was suggested that diethylcarbamazine may either combine with microfilarial protein to form allergens or stimulate microfilariae to produce sufficient allergen, which when bound to immunoglobulin E would cause mast cells to secrete vaso-active amines. Although no details were given, reference was made to preliminary results showing a rise in circulating histamine during the shock r e a~t i o n .~ This would support the view that a mast cell degranulating substance produces a shock reaction in the dog, clinically similar to that seen in D.
immitis-infected dogs treated with diethylcarbamazine.6 Histamine is known to be the major chemical mediator of anaphylaxis in dogs and results in constric-99 v9 number of microfilariae noted in the liver sections did not appear to be related to the number in circulation (table I) . This point was also noted in a previous study.I3 There did appear to be some correlation between the number in the liver and the seventy of the vascular reaction. This would support the view that the microfilariae play a central role in this shock-like syndrome.
The nature of the mediator and the means of its release of activation by the microfilariae under the influence of diethylcarbamazine remain unclear.
Apart from anaphylaxis, disseminated intravascular coagulation has to be considered as a factor in this reaction. It can cause a wide spectrum of pathophysiologic changes that range from rapid profound shock to a hemorrhagic diathesis, with death from hemorrhage.' I The shock is usually considered to result from obstruction of blood flow through the hepatic and pulmonary vessels as a result of thromboses, something which was observed occasionally in the smaller hepatic veins of the dogs reported here. Laboratory diagnosis in the acute phase of disseminated intravascular coagulation is dependent on detecting reductions in amounts of clotting factors, fibrinogen, platelet counts and an increase in the concentration of fibrinogen degradation products.', ' ' In the diethylcarbamazine reaction, unchanged plasma fibrinogen levels, a decrease in platelet count and increase in fibrinogen degradation products have been r e p~r t e d .~. '~ The lack of hemorrhagic lesions in tissues other than liver in the reactor dogs of this report would suggest that disseminated intravascular coagulation is a negligible factor.
In contrast to earlier studies13 not all microfilaremic dogs challenged with diethylcarbamazine had a clinical shock-like reaction. Because the cause of the reaction is not conclusively known, reasons for this variation can only be speculative. The comparison between dogs subjected to a single challenge (group I) and those to repeated challenges (group 11) showed that similar vascular reactions in the liver occurred. The only noted histological differences were the presence or hemosiderin in the group I1 dogs which would be consistent with hemorrhage that resulted from earlier diethylcarbamazine challenges and the development of mild fibroplasia around the central vein which could have been due to continual hepatocyte loss in this area, because of repetitive diethylcarbamazine vascular reactions. One notable feature was the lack of clinical reaction following the final challenge in four dogs in group I1 which had had repeated challenges. However, three of them did have moderate to severe vascular change in the liver after the last challenge. This would suggest that compensatory mechanisms, such as alternative venous return pathways to the heart, as a result of repeated challenges, may have become more efficient at overcoming the circulatory deficit, and therefore, any reaction which occurred was subclinical.
It would appear, therefore, that the reaction which occurs when diethylcarbamazine is administered to microfilaremic dogs is complex and could be mediated by more than one mechanism. While the chemical mediators of anaphylaxis such as histamine do not appear to play a role, the association between the numbers of microfilariae in the liver and the severity of the reaction support the view that a microfilarial factor is an important mediator. Further work is needed to clarify this reaction. 
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